Just-Evotec Biologics has announced that it will be expanding a partnership struck with Sandoz in 2023 to develop and manufacture biosimilars, potentially adding further biosimilars to the pair’s development pipeline and offering “further guarantees for Sandoz’s long-term commercial supply security.”
Last year, Sandoz and Just-Evotec announced a “multi-year” deal to develop and manufacture multiple biosimilars, in particular making use of...






